BIRC3 and B-cell chronic lymphocytic leukemia: Rossi et al. recently showed that genetic disruption of cIAP2 in chronic lymphocytic leukemia is associated with fludarabine resistance and a poor outcome similar to that attributed to TP53 abnormalities [42].